Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc is positioned favorably within the behavioral healthcare sector, with expectations of net PLGL liability increasing significantly, indicating strategic management of financial obligations. The company has demonstrated robust organic growth through the expansion of bed capacity in existing facilities and new developments, supported by healthy demand in the behavioral health market. Additionally, guidance indicating improved organic earnings growth suggests the potential for enhanced profitability, despite operational risks related to rising claims costs and competitive pressures in the market.

Bears say

Acadia Healthcare Co Inc has consistently revised its EBITDA guidance downward, with a current expectation for 2025 of $601-611 million, reflecting a $49 million reduction that contributes to a 13.4% decrease from initial estimates. The company's projections indicate persistently high litigation expenses, with anticipated costs of $100-110 million for 2026, which remain significantly above historical norms. Additionally, a prolonged period of volume softness is expected to result in FY26 EBITDA falling 5% below current estimates, reinforcing a negative outlook for the company's financial performance.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 23% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.